Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive Tract

NCT00511212 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

60

Enrollment

OTHER

Sponsor class

Stopped No eligible patient.

Conditions

Peritonitis
Postoperative Complications

Interventions

DRUG: intravenous immunoglobulin

Sponsor

Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group